• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多分割方法在基于前列腺特异性膜抗原靶向 F-DCFPyL PET/CT 的原发性前列腺癌容积勾画中的比较。

Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted F-DCFPyL PET/CT.

机构信息

School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing, China.

出版信息

J Nucl Med. 2024 Jan 2;65(1):87-93. doi: 10.2967/jnumed.123.266005.

DOI:10.2967/jnumed.123.266005
PMID:38050147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10755517/
Abstract

This study aimed to assess the accuracy of intraprostatic tumor volume measurements on prostate-specific membrane antigen-targeted F-DCFPyL PET/CT made with various segmentation methods. An accurate understanding of tumor volumes versus segmentation techniques is critical for therapy planning, such as radiation dose volume determination and response assessment. Twenty-five men with clinically localized, high-risk prostate cancer were imaged with F-DCFPyL PET/CT before radical prostatectomy. The tumor volumes and tumor-to-prostate ratios (TPRs) of dominant intraprostatic foci of uptake were determined using semiautomatic segmentation (applying SUV percentage [SUV%] thresholds of SUV30%-SUV70%), adaptive segmentation (using adaptive segmentation percentage [A%] thresholds of A30%-A70%), and manual contouring. The histopathologic tumor volume (TV-Histo) served as the reference standard. The significance of differences between TV-Histo and PET-based tumor volume were assessed using the paired-sample Wilcoxon signed-rank test. The Spearman correlation coefficient was used to establish the strength of the association between TV-Histo and PET-derived tumor volume. Median TV-Histo was 2.03 cm (interquartile ratio [IQR], 1.16-3.36 cm), and median TPR was 10.16%. The adaptive method with an A40% threshold most closely determined the tumor volume, with a median difference of +0.19 (IQR, -0.71 to +2.01) and a median relative difference of +7.6%. The paired-sample Wilcoxon test showed no significant difference in PET-derived tumor volume and TV-Histo using A40%, A50%, SUV40%, and SUV50% threshold segmentation algorithms ( > 0.05). For both threshold-based segmentation methods, use of higher thresholds (e.g., SUV60% or SUV70% and A50%-A70%) resulted in underestimation of tumor volumes, and use of lower thresholds (e.g., SUV30% or SUV40% and A30%) resulted in overestimation of tumor volumes relative to TV-Histo and TPR. Manual segmentation overestimated the tumor volume, with a median difference of +2.49 (IQR, 0.42-4.11) and a median relative difference of +130%. Segmentation of intraprostatic tumor volume and TPR with an adaptive segmentation approach most closely approximates TV-Histo. This information might be used to guide the primary treatment of men with clinically localized, high-risk prostate cancer.

摘要

这项研究旨在评估使用不同分割方法在前列腺特异性膜抗原靶向 F-DCFPyL PET/CT 上进行前列腺内肿瘤体积测量的准确性。准确了解肿瘤体积与分割技术之间的关系对于治疗计划至关重要,例如辐射剂量体积确定和反应评估。 25 名患有临床局限性高危前列腺癌的男性在根治性前列腺切除术前接受 F-DCFPyL PET/CT 成像。使用半自动分割(应用 SUV30%-SUV70%的 SUV 百分比 [SUV%]阈值)、自适应分割(应用 A30%-A70%的自适应分割百分比 [A%]阈值)和手动轮廓测定法确定优势前列腺内摄取灶的肿瘤体积和肿瘤与前列腺比值(TPR)。组织病理学肿瘤体积(TV-Histo)作为参考标准。使用配对样本 Wilcoxon 符号秩检验评估 TV-Histo 与基于 PET 的肿瘤体积之间差异的显著性。Spearman 相关系数用于建立 TV-Histo 与 PET 衍生肿瘤体积之间关联的强度。 中位 TV-Histo 为 2.03cm(四分位距 [IQR],1.16-3.36cm),中位 TPR 为 10.16%。具有 A40%阈值的自适应方法最能准确确定肿瘤体积,中位差异为+0.19(IQR,-0.71 至+2.01),中位相对差异为+7.6%。配对样本 Wilcoxon 检验显示,使用 A40%、A50%、SUV40%和 SUV50%阈值分割算法时,基于 PET 的肿瘤体积与 TV-Histo 之间无显著差异(>0.05)。对于基于阈值的分割方法,使用更高的阈值(例如,SUV60%或 SUV70%和 A50%-A70%)会导致肿瘤体积低估,而使用更低的阈值(例如,SUV30%或 SUV40%和 A30%)会导致肿瘤体积相对于 TV-Histo 和 TPR 高估。手动分割高估了肿瘤体积,中位差异为+2.49(IQR,0.42-4.11),中位相对差异为+130%。 使用自适应分割方法对前列腺内肿瘤体积和 TPR 进行分割最接近 TV-Histo。这些信息可能有助于指导具有临床局限性高危前列腺癌的男性的主要治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747f/10755517/9e8e052fcd24/jnumed.123.266005absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747f/10755517/9e8e052fcd24/jnumed.123.266005absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747f/10755517/9e8e052fcd24/jnumed.123.266005absf1.jpg

相似文献

1
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted F-DCFPyL PET/CT.多分割方法在基于前列腺特异性膜抗原靶向 F-DCFPyL PET/CT 的原发性前列腺癌容积勾画中的比较。
J Nucl Med. 2024 Jan 2;65(1):87-93. doi: 10.2967/jnumed.123.266005.
2
Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate Cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mL.基于 PSMA 的 18 F-DCFPyL PET/CT 在 PSA 水平≤0.2ng/mL 的前列腺癌患者确定性治疗后对前列腺癌的诊断性能。
Clin Nucl Med. 2023 Dec 1;48(12):1021-1027. doi: 10.1097/RLU.0000000000004893. Epub 2023 Oct 5.
3
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.阴性前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描能否避免新诊断前列腺癌患者进行盆腔淋巴结清扫?一项以病理组织学为参考标准的系统评价和Meta分析
Eur Urol Oncol. 2022 Feb;5(1):1-17. doi: 10.1016/j.euo.2021.08.001. Epub 2021 Sep 17.
4
A comparison between two image reconstructions on the measures of prostate-specific membrane antigen-positive tumor volume in 18 F-PSMA-JK-7-PET/computed tomography.18F-PSMA-JK-7正电子发射断层扫描/计算机断层扫描中两种图像重建方法对前列腺特异性膜抗原阳性肿瘤体积测量的比较。
Nucl Med Commun. 2025 Oct 1;46(10):967-971. doi: 10.1097/MNM.0000000000002021. Epub 2025 Jun 24.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Is 18 F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?18F-氟化物PET/CT是诊断全关节置换术后假体松动的准确工具吗?
Clin Orthop Relat Res. 2025 Mar 1;483(3):415-428. doi: 10.1097/CORR.0000000000003228. Epub 2024 Sep 11.
7
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment.前列腺特异性膜抗原正电子发射断层扫描在前列腺癌明确治疗前诊断和初始分期中作用的综合系统评价与荟萃分析
Eur Urol. 2025 Jun;87(6):654-671. doi: 10.1016/j.eururo.2025.03.003. Epub 2025 Mar 27.
8
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.前列腺特异性膜抗原示踪剂在前列腺癌生化复发中的正电子发射断层扫描/计算机断层扫描检测率:系统评价和网络荟萃分析。
J Urol. 2021 Feb;205(2):356-369. doi: 10.1097/JU.0000000000001369. Epub 2020 Sep 16.
9
Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.正电子发射断层扫描/计算机断层扫描成像在检测和管理复发性宫颈癌中的应用:证据的系统评价、主观概率的 elicitation 和经济建模。
Health Technol Assess. 2013 Mar;17(12):1-323. doi: 10.3310/hta17120.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

引用本文的文献

1
Utility of F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy.F-DCFPyL PET对接受根治性前列腺切除术的高风险或极高风险前列腺癌患者进行局部分期的效用。
Eur J Nucl Med Mol Imaging. 2025 Feb 10. doi: 10.1007/s00259-025-07133-1.
2
A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical Specimens.一种基于肺癌患者 FDG-PET 影像组学特征的肿瘤体积分割算法,采用手术标本进行验证。
Diagnostics (Basel). 2024 Nov 25;14(23):2654. doi: 10.3390/diagnostics14232654.